New drug tested to ease debilitating fibroid symptoms
NCT ID NCT05445167
Summary
This study tested whether an investigational drug called KLH-2109 could better reduce heavy menstrual bleeding and pain in women with uterine fibroids compared to a placebo. It involved 89 premenopausal Japanese women who experienced these symptoms. The main goal was to see if the drug could significantly lower bleeding scores and pain levels over a 12-week treatment period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE FIBROIDS (MESH HEADING: LEIOMYOMA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Site
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.